Tag: Regulatory Compliance

New Fraud Prevention Measures Impacting Medicare and Medicaid

Learn about new measures targeting Medicare and Medicaid fraud, including enrollment freezes and increased investigations to protect against fraudulent activities.

Recent Court Decisions Impacting Insurance Coverage and Liability

Explore key recent court rulings affecting insurance coverage, UIM regulations, and liability implications for rental car companies in various states.

Quarterly Earnings Insights for P&C Insurers in 2026

Discover key insights from the quarterly earnings of property and casualty insurers, highlighting industry challenges and market performance trends for 2026.

Kennedys Strengthens Corporate Division with New Appointments

Kennedys boosts its corporate division by appointing new partners, enhancing expertise in M&A and financial crime, supporting insurance intermediaries.

Navigating the Evolving Insurance Industry: Key Insights for Investors

Explore essential insights on the insurance industry for investors, focusing on profitability and market shifts for long-term success.

Settlement Reached for False Claims in Illinois Nursing Facilities

Illinois nursing facilities reach $300K settlement over false Medicare claims, emphasizing the significance of compliance and patient-centered care.

CBO Presentation on Medicare Part D and Healthcare Financing Reform

Join us for a pivotal CBO presentation on Medicare Part D's impacts on health financing reforms. Insights on policy changes and budget strategies await.

RAAPID INC Launches Risk Adjustment Platform to Improve Medicare Advantage Compliance

RAAPID INC's new Risk Adjustment Platform enhances compliance and coding accuracy for Medicare Advantage, addressing fiscal and regulatory challenges effectively.

Foley & Lardner Welcomes Shannon Kukulka to Strengthen Employee Benefits Practice

Foley & Lardner boosts its Nashville office with Shannon Kukulka, enhancing employee benefits expertise across healthcare and insurance sectors. Read more!

Potential $529 Billion Savings from MFN Drug Proposal: Transparency and Regulatory Impact

Explore the potential $529 billion savings from the MFN drug pricing proposal, while emphasizing the need for transparency in pharmaceutical agreements and regulatory compliance.